The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets
暂无分享,去创建一个
J. de Moraes | M. Salvadori | Fernanda S. Teixeira | D. Rando | T. Pavani | G. A. Santos | M. Espírito-Santo | Ana C Mengarda | Rayssa A. Cajas | Vinícius Roquini | Milene F. Martins-da-Silva | Julia Godoy-Silva | Vanusa A. Melo
[1] Islam M. Ibrahim,et al. Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms. , 2023, European journal of pharmacology.
[2] J. de Moraes,et al. Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni , 2022, Scientific Reports.
[3] M. Zucchetti,et al. Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice , 2022, Pharmaceutics.
[4] J. de Moraes,et al. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. , 2022, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[5] J. de Moraes,et al. Susceptibility of Angiostrongylus cantonensis Larvae to Anthelmintic Drugs , 2022, Frontiers in Pharmacology.
[6] J. de Moraes,et al. Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis , 2022, Frontiers in Pharmacology.
[7] J. de Moraes,et al. Approaches to advance drug discovery for neglected tropical diseases. , 2022, Drug discovery today.
[8] J. de Moraes,et al. Recent trends in praziquantel nanoformulations for helminthiasis treatment , 2022, Expert opinion on drug delivery.
[9] L. Ouyang,et al. Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study , 2022, Respiratory Research.
[10] B. Spengler,et al. Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis , 2022, Molecules.
[11] L. Freire-de-Lima,et al. Trypanosoma cruzi trans-Sialidase as a Potential Vaccine Target Against Chagas Disease , 2021, Frontiers in Cellular and Infection Microbiology.
[12] V. Nyamori,et al. Lactate dehydrogenase and malate dehydrogenase: Potential antiparasitic targets for drug development studies. , 2021, Bioorganic & medicinal chemistry.
[13] M. Salvadori,et al. Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni , 2021, Pharmaceuticals.
[14] J. de Moraes,et al. Licarin A, a neolignan isolated from Nectandra oppositifolia Nees & Mart. (Lauraceae), exhibited moderate preclinical efficacy against Schistosoma mansoni infection , 2021, Phytotherapy research : PTR.
[15] M. Malecela,et al. A road map for neglected tropical diseases 2021–2030 , 2021, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[16] J. de Moraes,et al. 15β-Senecioyl-oxy-ent-kaur-16-en-19-oic Acid, a Diterpene Isolated from Baccharis lateralis, as Promising Oral Compound for the Treatment of Schistosomiasis. , 2020, Journal of natural products.
[17] J. de Moraes,et al. Brazilian red propolis exhibits antiparasitic properties in vitro and reduces worm burden and egg production in an mouse model harboring either early or chronic Schistosoma mansoni infection. , 2020, Journal of ethnopharmacology.
[18] J. de Moraes,et al. Therapeutic Effect of Diminazene Aceturate on Parasitic Blood Fluke Schistosoma mansoni Infection , 2020, Antimicrobial Agents and Chemotherapy.
[19] J. de Moraes,et al. Schiff bases of 4-Phenyl-2-Aminothiazoles as hits to new antischistosomals: Synthesis, in vitro, in vivo and in silico studies. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] J. de Moraes,et al. FDA-Approved Antiparasitic Drugs in the 21st Century: A Success for Helminthiasis? , 2020, Trends in parasitology.
[21] J. Utzinger,et al. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d’Ivoire , 2020, Parasites & Vectors.
[22] J. de Moraes,et al. Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis. , 2020, Acta tropica.
[23] J. Webster,et al. Schistosomiasis - assessing progress towards the 2020 and 2025 global goals , 2019, The New England journal of medicine.
[24] J. de Moraes,et al. Promethazine Exhibits Antiparasitic Properties In Vitro and Reduces Worm Burden, Egg Production, Hepatomegaly, and Splenomegaly in a Schistosomiasis Animal Model , 2019, Antimicrobial Agents and Chemotherapy.
[25] C. Bailly. Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment. , 2019, Drug discovery today.
[26] Leonardo L. G. Ferreira,et al. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis , 2019, EBioMedicine.
[27] J. de Moraes,et al. In Vitro and In Vivo Studies of Spironolactone as an Antischistosomal Drug Capable of Clinical Repurposing , 2018, Antimicrobial Agents and Chemotherapy.
[28] R. Bergquist,et al. Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis , 2018, Tropical medicine and infectious disease.
[29] M. Brewer,et al. Praziquantel Resistance in the Zoonotic Cestode Dipylidium caninum. , 2018, The American journal of tropical medicine and hygiene.
[30] P. Sanseau,et al. Drug repurposing: progress, challenges and recommendations , 2018, Nature Reviews Drug Discovery.
[31] Andrew I. Su,et al. The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis , 2018, Proceedings of the National Academy of Sciences.
[32] J. de Moraes,et al. Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity , 2018, PloS one.
[33] R. Wiegand,et al. A Persistent Hotspot of Schistosoma mansoni Infection in a Five-Year Randomized Trial of Praziquantel Preventative Chemotherapy Strategies , 2017, The Journal of infectious diseases.
[34] J. Keiser,et al. Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial , 2017, The Lancet. Global health.
[35] B. Begović,et al. Open Clinical Trial on Using Nifuroxazide Compared to Probiotics in Treating Acute Diarrhoeas in Adults , 2016, Materia socio-medica.
[36] J. de Moraes,et al. Flavonoids and Sesquiterpene Lactones from Artemisia absinthium and Tanacetum parthenium against Schistosoma mansoni Worms , 2016, Evidence-based complementary and alternative medicine : eCAM.
[37] P. Mäser,et al. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning , 2015, PloS one.
[38] J. de Moraes,et al. Antischistosomal Activity of Oxindolimine-Metal Complexes , 2015, Antimicrobial Agents and Chemotherapy.
[39] L. Sibley,et al. Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans. , 2015, Trends in pharmacological sciences.
[40] X. Song,et al. Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model , 2015, Cell Death and Disease.
[41] J. de Moraes,et al. Antischistosomal Activity of the Terpene Nerolidol , 2014, Molecules.
[42] D. Rollinson,et al. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns. , 2013, Acta tropica.
[43] J. Keiser,et al. In Vitro Synergistic Interaction Between Amide Piplartine and Antimicrobial Peptide Dermaseptin Against Schistosoma mansoni Schistosomula and Adult Worms , 2012 .
[44] Ying Liu,et al. Chemical markers' fishing and knockout for holistic activity and interaction evaluation of the components in herbal medicines. , 2010, Journal of chromatography. A.
[45] D. Chauhan,et al. Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3. , 2008, Blood.
[46] E. Ferreira,et al. Antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides. , 2008, Bioorganic & medicinal chemistry.
[47] Luc Kestens,et al. Human schistosomiasis , 2006, The Lancet.
[48] Ashutosh Kumar Singh,et al. Visceral schistosomiasis of domestic animals in India: humoral immune status of infected cattle, sheep and goats against major polypeptide antigens of Schistosoma indicum and S. spindale , 2004, Parasite immunology.
[49] E. Ferreira,et al. Potential tuberculostatic agents. Topliss application on benzoic acid [(5-nitro-thiophen-2-yl)-methylene]-hydrazide series. , 2002, Bioorganic & medicinal chemistry.
[50] J. Iredale,et al. Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases. , 2000, Histology and histopathology.
[51] V. Yardley,et al. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase. , 1999, Biochemical pharmacology.
[52] J. Bennett,et al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. , 1996, The American journal of tropical medicine and hygiene.
[53] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[54] J. Chaput,et al. [Double-blind controlled study of the efficacy of nifuroxazide versus placebo in the treatment of acute diarrhea in adults]. , 1989, Gastroentérologie Clinique et Biologique.
[55] J. Moreau,et al. Comparative physiological disposition of two nitrofuran anti-microbial agents. , 1986, Biopharmaceutics & drug disposition.
[56] J. Keiser,et al. Improving translational power in antischistosomal drug discovery. , 2022, Advances in parasitology.
[57] Priscila de Faria Pinto,et al. ATP-Diphosphohydrolases in Parasites: Localization, Functions and Recent Developments in Drug Discovery. , 2019, Current protein & peptide science.
[58] J. Moraes,et al. Vanillin-Related N-Acylhydrazones: Synthesis, Antischistosomal Properties and Target Fishing Studies. , 2019, Current topics in medicinal chemistry.
[59] J. de Moraes,et al. Antischistosomal agents: state of art and perspectives. , 2018, Future medicinal chemistry.
[60] P. Rampal,et al. Prevention and treatment of traveler's diarrhea: a clinical pharmacological approach. , 1995, Chemotherapy.